Summary
CVS Health Corporation (CVS) announced a significant strategic move through a definitive merger agreement to acquire Omnicare, Inc. for approximately $10.6 billion in cash. This acquisition includes assuming Omnicare's existing debt of approximately $2.3 billion. The transaction, structured as a merger of CVS Pharmacy's subsidiary with Omnicare, aims to expand CVS Health's reach and capabilities. The deal is subject to customary closing conditions, including Omnicare shareholder approval and regulatory clearances, such as antitrust approvals. Omnicare's board has unanimously recommended its shareholders vote in favor of the merger. This filing provides the initial details of this material definitive agreement, outlining the key terms and conditions, and signaling a substantial investment by CVS Health to enhance its market position.
Key Highlights
- 1CVS Health to acquire Omnicare, Inc. for approximately $10.6 billion in cash.
- 2CVS Health will also assume approximately $2.3 billion of Omnicare's debt.
- 3The transaction is structured as a merger where Omnicare will become a wholly owned subsidiary of CVS Health.
- 4The deal is contingent upon approval from Omnicare's stockholders and regulatory bodies, including antitrust reviews.
- 5Omnicare's Board of Directors has unanimously recommended its shareholders approve the merger agreement.
- 6The Merger Agreement includes customary representations, warranties, and covenants, with both parties agreeing to use reasonable best efforts to close the transaction.
- 7Omnicare has agreed to cease discussions with other parties regarding alternative acquisition proposals and will not solicit such offers, with limited exceptions for fiduciary duties.